AstraZeneca PLC

Return on Assets, %

6.1

-2.7

Net income margin, %

7.9

2.8

EBITDA margin, %

19

10.8

Debt to Equity, %

73.1

19.2

Intangible assets and goodwill, %

57.4

3.6

Revenue CAGR 3Y, %

19.8

8.5

Total Equity change 1Y, %

5.6

0

Revenue Y, % chg

3.2

0.5

P/E

36.1

22.7

P/BV

5.4

1.5

P/S

4.6

2.3

EV/S

5.1

2.4

EV/EBITDA

17.5

7.4

Average Analyst recommendation

Buy

Buy

Average upside forecasts, %

18.5

51.3

Forward P/E

14.6

15.6

Dividend Yield, %

2

1.7

Forward Dividend Yield, %

2.9

0.2

Expected dividend per share

2

0

Payout Ratio, %

75.2

30.3

Dividend Ex Date

2024-02-22